Advanced Search Close Search
Commentary

Physician anesthesiologists need to know if you’re taking Ozempic or another GLP-1 drug

  • Dr. Matt Dellaquila

As a physician anesthesiologist, I see patients taking a GLP-1, like Ozempic, Wegovy, or Zepbound, every single day. Use of these drugs, originally intended for diabetes, has skyrocketed as people take them for weight loss, sleep apnea, and cardiovascular health. There is still much to learn about these medications, but we know they present challenges […]

States Newsroom

Indiana Medicaid will cover GLP-1s for obesity

  • Mackenzi Klemann

Hoosiers insured through Medicaid will soon gain access to GLP-1 medications for obesity. Gov. Mike Braun on Thursday directed the Indiana Family and Social Services Administration, which administers Medicaid benefits to 1.9 million Hoosiers, to participate in a federal initiative to cover GLP-1 medications for obesity. The Centers for Medicare & Medicaid Innovation Center is […]

Travel

Rising GLP-1 Use Linked to Protein, Fiber and Vitamin Deficiencies, Study Shows

  • Karen Kelly

Nearly one in four U.S. households reports using a GLP-1 medication, and projections suggest that figure could rise to 35 percent by 2030. However, new research shows many users may not be getting enough essential nutrients when taking these drugs, causing concerns about vitamin and mineral deficiencies as use grows.